Back to 
CAPITAL FUND MANAGEMENT S.A.
CAPITAL FUND MANAGEMENT S.A.
LGND
Showing 0 of 2 quarters
Position history for CAPITAL FUND MANAGEMENT S.A.'s holdings in LIGAND PHARMACEUTICALS INC
No. Capital Fund Management exited its LGND (Ligand Pharmaceuticals) position in Q3 2019. Its Q2 2019 13F listed 2,080 shares worth $237,000. Capital Fund Management first reported LGND in Q2 2019 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.